Sera Prognostics, Inc.
Laboratory testing company · Salt Lake City, Utah, United States · Nasdaq: SERA
Sera Prognostics, Inc. is a laboratory testing company headquartered in Salt Lake City, Utah, United States. Its earliest recorded incorporation is in 2008. Its shares trade on Nasdaq under the ticker SERA. It has reported private securities offerings to the US SEC, most recently $100 million sold in a notice filed in 2021.
Sera Prognostics at a glance
What does Sera Prognostics do?
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $100.3 million sold (2021).
Frequently asked questions about Sera Prognostics
Where is Sera Prognostics headquartered?
Sera Prognostics, Inc. is headquartered in Salt Lake City, Utah, United States.
What does Sera Prognostics do?
Sera Prognostics, Inc. is a laboratory testing company. Its SEC industry classification is Services-Medical Laboratories.
Is Sera Prognostics a public company?
Yes. Sera Prognostics, Inc. trades on Nasdaq under the ticker SERA.
When was Sera Prognostics founded?
The earliest incorporation on record for Sera Prognostics, Inc. is in 2008, according to public company registers.
Similar companies
- Exact Sciences CorpMadison, Wisconsin, United States
- Guardant Health, Inc.Palo Alto, California, United States
- CareDx, Inc.Brisbane, California, United States
- Biodesix IncLouisville, Colorado, United States
- Dxterity Diagnostics IncCompton, California, United States
- Veracyte, Inc.South San Francisco, California, United States
- Aclarion, Inc.Broomfield, Colorado, United States
- Foundation Medicine, Inc.Cambridge, Massachusetts, United States
Work with CROs and CDMOs like Sera Prognostics
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.